These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


133 related items for PubMed ID: 15740999

  • 1. Anxiety and salivary cortisol in symptomatic and nonsymptomatic panic patients and healthy volunteers performing simulated public speaking.
    Garcia-Leal C, Parente AC, Del-Ben CM, Guimarães FS, Moreira AC, Elias LL, Graeff FG.
    Psychiatry Res; 2005 Feb 28; 133(2-3):239-52. PubMed ID: 15740999
    [Abstract] [Full Text] [Related]

  • 2. The effect of stress on salivary cortisol in panic disorder patients.
    Stones A, Groome D, Perry D, Hucklebridge F, Evans P.
    J Affect Disord; 1999 Feb 28; 52(1-3):197-201. PubMed ID: 10357033
    [Abstract] [Full Text] [Related]

  • 3. Salivary cortisol levels in persons with and without different anxiety disorders.
    Vreeburg SA, Zitman FG, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, Hoogendijk WJ, Smit JH, Penninx BW.
    Psychosom Med; 2010 May 28; 72(4):340-7. PubMed ID: 20190128
    [Abstract] [Full Text] [Related]

  • 4. Salivary cortisol in panic: are males more vulnerable?
    van Duinen MA, Schruers KR, Jaegers E, Maes M, Griez EJ.
    Neuro Endocrinol Lett; 2004 Oct 28; 25(5):386-90. PubMed ID: 15580175
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A striking pattern of cortisol non-responsiveness to psychosocial stress in patients with panic disorder with concurrent normal cortisol awakening responses.
    Petrowski K, Herold U, Joraschky P, Wittchen HU, Kirschbaum C.
    Psychoneuroendocrinology; 2010 Apr 28; 35(3):414-21. PubMed ID: 19913360
    [Abstract] [Full Text] [Related]

  • 7. Salivary α-amylase and cortisol responsiveness following electrical stimulation stress in panic disorder patients.
    Tanaka Y, Ishitobi Y, Maruyama Y, Kawano A, Ando T, Imanaga J, Okamoto S, Kanehisa M, Higuma H, Ninomiya T, Tsuru J, Hanada H, Isogawa K, Akiyoshi J.
    Neurosci Res; 2012 May 28; 73(1):80-4. PubMed ID: 22391145
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CO2 challenge results in hypothalamic-pituitary-adrenal activation in healthy volunteers.
    van Duinen MA, Schruers KR, Maes M, Griez EJ.
    J Psychopharmacol; 2005 May 28; 19(3):243-7. PubMed ID: 15888509
    [Abstract] [Full Text] [Related]

  • 11. Panic induced by carbon dioxide inhalation and lack of hypothalamic-pituitary-adrenal axis activation.
    Sinha SS, Coplan JD, Pine DS, Martinez JA, Klein DF, Gorman JM.
    Psychiatry Res; 1999 May 31; 86(2):93-8. PubMed ID: 10397411
    [Abstract] [Full Text] [Related]

  • 12. Salivary alpha-amylase and cortisol responsiveness to stress in first episode, drug-naïve patients with panic disorder.
    Altamura M, Iuso S, Balzotti A, Francavilla G, Dimitri A, Cibelli G, Bellomo A, Petito A.
    Neurosci Res; 2018 Dec 31; 137():49-56. PubMed ID: 29550536
    [Abstract] [Full Text] [Related]

  • 13. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K, Wintermann GB, Kirschbaum C, Bornstein SR.
    Psychoneuroendocrinology; 2012 Aug 31; 37(8):1199-208. PubMed ID: 22277728
    [Abstract] [Full Text] [Related]

  • 14. HPA axis activity in patients with panic disorder: review and synthesis of four studies.
    Abelson JL, Khan S, Liberzon I, Young EA.
    Depress Anxiety; 2007 Aug 31; 24(1):66-76. PubMed ID: 16845643
    [Abstract] [Full Text] [Related]

  • 15. Subjective and neurovegetative changes in healthy volunteers and panic patients performing simulated public speaking.
    Parente AC, Garcia-Leal C, Del-Ben CM, Guimarães FS, Graeff FG.
    Eur Neuropsychopharmacol; 2005 Dec 31; 15(6):663-71. PubMed ID: 15961294
    [Abstract] [Full Text] [Related]

  • 16. Salivary, total plasma and plasma free cortisol in panic disorder.
    Wedekind D, Bandelow B, Broocks A, Hajak G, Rüther E.
    J Neural Transm (Vienna); 2000 Dec 31; 107(7):831-7. PubMed ID: 11005547
    [Abstract] [Full Text] [Related]

  • 17. Circadian cortisol, depressive symptoms and neurological impairment in early multiple sclerosis.
    Kern S, Schultheiss T, Schneider H, Schrempf W, Reichmann H, Ziemssen T.
    Psychoneuroendocrinology; 2011 Nov 31; 36(10):1505-12. PubMed ID: 21621332
    [Abstract] [Full Text] [Related]

  • 18. Cortisol as an indicator of hypothalmic-pitituary-adrenal axis dysregulation in patients with panic disorder: a literature review.
    Jakuszkowiak-Wojten K, Landowski J, Wiglusz MS, Cubała WJ.
    Psychiatr Danub; 2015 Sep 31; 27 Suppl 1():S445-51. PubMed ID: 26417813
    [Abstract] [Full Text] [Related]

  • 19. Salivary cortisol, serum lipids, and adiposity in patients with depressive and anxiety disorders.
    Veen G, Giltay EJ, DeRijk RH, van Vliet IM, van Pelt J, Zitman FG.
    Metabolism; 2009 Jun 31; 58(6):821-7. PubMed ID: 19375126
    [Abstract] [Full Text] [Related]

  • 20. Salivary cortisol response during exposure treatment in driving phobics.
    Alpers GW, Abelson JL, Wilhelm FH, Roth WT.
    Psychosom Med; 2003 Jun 31; 65(4):679-87. PubMed ID: 12883122
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.